FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Stuart Gordon

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Hepacivirus

Anatomy

Livers

Procedures

Concepts & Ideas

Physiology

Genotype

Co-author Network

Publications

TOP 3
Humberto C Gonzalez; Syed Mohammed Jafri; Stuart Gordon
Role of liver biopsy in the era of direct-acting antivirals.
Dwayne M Baxa; Katyna Borroto-Esoda; Brandi J Chappell; Alicia Golembieski; John Jovanovich; Anne Kizy; Prashant V Krishnan; Omar Sharif; Lynne Shetron-Rama; Andrea Snow-Lampart; Ashish D Thekdi; Stuart Gordon
Evaluation of anti-HBV drug resistant mutations among patients with acute symptomatic hepatitis B in the United States.
Anne C Moorman; Cynthia C Nakasato; David Nerenz; Nancy J Oja-Tebbe; Loralee B Rupp; Philip R Spradling; Eyasu H Teshale; John W Ward; Jian Xing; Joseph A Boscarino; Stuart Gordon; Emily M Henkle; Scott D Holmberg; Mei Lu
Baseline characteristics and mortality among people in care for chronic viral hepatitis: the chronic hepatitis cohort study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Stuart Gordon (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Humberto C Gonzalez; Syed Mohammed Jafri; Stuart Gordon
Role of liver biopsy in the era of direct-acting antivirals.
Current gastroenterology reports 2013;15(2):307.
2013: Dwayne M Baxa; Katyna Borroto-Esoda; Brandi J Chappell; Alicia Golembieski; John Jovanovich; Anne Kizy; Prashant V Krishnan; Omar Sharif; Lynne Shetron-Rama; Andrea Snow-Lampart; Ashish D Thekdi; Stuart Gordon
Evaluation of anti-HBV drug resistant mutations among patients with acute symptomatic hepatitis B in the United States.
Journal of hepatology 2013;58(2):212-6.
2013: Anne C Moorman; Cynthia C Nakasato; David Nerenz; Nancy J Oja-Tebbe; Loralee B Rupp; Philip R Spradling; Eyasu H Teshale; John W Ward; Jian Xing; Joseph A Boscarino; Stuart Gordon; Emily M Henkle; Scott D Holmberg; Mei Lu
Baseline characteristics and mortality among people in care for chronic viral hepatitis: the chronic hepatitis cohort study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013;56(1):40-50.
2012: Syed-Mohammed Jafri; Stuart Gordon
Care of the cirrhotic patient.
Infectious disease clinics of North America 2012;26(4):979-94.
2012: Stuart Gordon; Ami Buikema; Robert S Hoop; David Nerenz; Paul J Pockros; Norah A Terrault; Fayez M Hamzeh
Impact of disease severity on healthcare costs in patients with chronic hepatitis C (CHC) virus infection.
Hepatology (Baltimore, Md.) 2012;56(5):1651-60.
2012: Philip R Spradling; Eyasu H Teshale; Joseph A Boscarino; Maxine M Denniston; Stuart Gordon; Emily M Henkle; Scott D Holmberg; Mei Lu; Anne C Moorman; Cynthia Nakasato; David Nerenz; Loralee Rupp
Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55(8):1047-55.
2012: F Fred Poordad; Thierry Poynard; Heather L Sings; Vilma Sniukiene; Mark S Sulkowski; Stefan Zeuzem; Janice K Albrecht; Bruce R Bacon; Navdeep Boparai; Clifford A Brass; Jean-Pierre Bronowicki; Margaret H Burroughs; Stuart Gordon; Venkata S Goteti; Ira M Jacobson; Cliona Molony; Timothy R Morgan; Lisa Pedicone
Factors that predict response of patients with hepatitis C virus infection to boceprevir.
Gastroenterology 2012;143(3):608-18.e1-5.
2012: Elliot B Tapper; Bruce Bacon; Tracy Challies; Eric B Cohen; Stuart Gordon; Eric Lawitz; Imad A Nasser; David Nelson; Keyur Patel; Nezam H Afdhal
Levels of alanine aminotransferase confound use of transient elastography to diagnose fibrosis in patients with chronic hepatitis C virus infection.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2012;10(8):932-937.e1.
2012: Maria C Segovia; Wadih Chacra; Stuart Gordon
Adefovir dipivoxil in chronic hepatitis B: history and current uses.
Expert opinion on pharmacotherapy 2012;13(2):245-54.
2012: David R Nelson; Nancy S Reau; Kenneth Sherman; Mark S Sulkowski; Nora Terrault; Greg Everson; Michael W Fried; Stuart Gordon; Ira Jacobson; Donald M Jensen; David L Thomas
Hepatitis C virus: a critical appraisal of new approaches to therapy.
Hepatitis research and treatment 2012;2012():138302.
2011: Stuart Gordon
Utility of IL-28B Polymorphisms in the Era of Direct-Acting Antiviral Therapy.
Gastroenterology & hepatology 2011;7(8):531-3.
2011: A J Muir; K-Q Hu; Stuart Gordon; K Koury; N Boparai; S Noviello; J K Albrecht; Mark S Sulkowski; J McCone
Hepatitis C treatment among racial and ethnic groups in the IDEAL trial.
Journal of viral hepatitis 2011;18(4):e134-43.
2011: Bruce R Bacon; Stuart Gordon; Eric Lawitz; Patrick Marcellin; John M Vierling; Stefan Zeuzem; F Fred Poordad; Zachary D Goodman; Heather L Sings; Navdeep Boparai; Margaret Burroughs; Clifford A Brass; Janice K Albrecht; Rafael Esteban
Boceprevir for previously treated chronic HCV genotype 1 infection.
The New England journal of medicine 2011;364(13):1207-17.
2011: Michelle M Mitchell; Ana Lleo; Luca Zammataro; Marlyn J Mayo; Pietro Invernizzi; Nancy Bach; Shinji Shimoda; Stuart Gordon; Mauro Podda; M Eric Gershwin; Carlo Selmi; Janine M LaSalle
Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis.
Epigenetics : official journal of the DNA Methylation Society 2011;6(1):95-102.
2010: Andrew J Muir; Mitchell L Shiffman; Atif Zaman; Boris Yoffe; Andrew de la Torre; Steven Flamm; Stuart Gordon; Paul Marotta; John M Vierling; Juan Carlos Lopez-Talavera; Kelly Byrnes-Blake; David Fontana; Jeremy Freeman; Todd Gray; Diana Hausman; Naomi N Hunder; Eric Lawitz
Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection.
Hepatology (Baltimore, Md.) 2010;52(3):822-32.
2010: Paul Y Kwo; Eric J Lawitz; Jonathan McCone; Eugene R Schiff; John M Vierling; David Pound; Mitchell N Davis; Joseph S Galati; Stuart Gordon; Natarajan Ravendhran; Lorenzo Rossaro; Frank H Anderson; Ira M Jacobson; Raymond Rubin; Kenneth Koury; Lisa Pedicone; Clifford A Brass; Eirum Chaudhri; Janice K Albrecht
Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial.
Lancet 2010;376(9742):705-16.
2010: Stuart Gordon; Dilip Moonka; Kimberly A Brown; Craig Rogers; Mary Ann Y Huang; Neal Bhatt; Lois Lamerato
Risk for renal cell carcinoma in chronic hepatitis C infection.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010;19(4):1066-73.
2010: I-Chin Wu; Ching-Lung Lai; Steven-Huy Bui Han; Kwang-Hyup Han; Stuart Gordon; You-Chen Chao; Chee-Kiat Tan; William Sievert; Tawesak Tanwandee; Dong Xu; Boon-Leong Neo; Ting-Tsung Chang
Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage.
Hepatology (Baltimore, Md.) 2010;51(4):1185-9.
2009: Vinod K Rustgi; William M Lee; Eric Lawitz; Stuart Gordon; Nezam Afdhal; Fred Poordad; Herbert L Bonkovsky; Leif Bengtsson; Gurudatt Chandorkar; Matthew Harding; Lindsay McNair; Molly Aalyson; John Alam; Robert Kauffman; SHAHIN GHARAKHANIAN; John G McHutchison
Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders.
Hepatology (Baltimore, Md.) 2009;50(6):1719-26.
2009: Robert G Gish; Stuart Gordon; David Nelson; Vinod Rustgi; Israel Rios
A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinoma.
Hepatology international 2009;3(3):480-9.
2009: Zhen-Zhou Feng; Jeffrey Tang; Dean Y Kim; Kimberly A Brown; Marwan Abouljoud; Stuart Gordon; Atsushi Yoshida; Mary Ann Huang; George Divine; Dilip Moonka
Renal insufficiency after liver transplantation in the MELD era compared to the pre-MELD era.
Clinical transplantation 2009;23(5):637-42.
2009: Prashant V Krishnan; Zhen-Zhou Feng; Stuart Gordon
Prolonged intrahepatic cholestasis and renal failure secondary to anabolic androgenic steroid-enriched dietary supplements.
Journal of clinical gastroenterology 2009;43(7):672-5.
2009: Raymond Cheng; James C Barton; Elizabeth D Morrison; Pradyumna D Phatak; Edward L Krawitt; Stuart Gordon; Kris V Kowdley
Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes.
Journal of clinical gastroenterology 2009;43(6):569-73.
2009: John G McHutchison; Gregory T Everson; Stuart Gordon; Ira M Jacobson; Mark S Sulkowski; Robert Kauffman; Lindsay McNair; John Alam; Andrew J Muir
Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection.
The New England journal of medicine 2009;360(18):1827-38.
2009: Stuart Gordon; Kenneth E Sherman
Treatment of HBV/HCV coinfection: releasing the enemy within.
Gastroenterology 2009;136(2):393-6.
2008: Fadi Antaki; M Margaret French; Dilip Moonka; Stuart Gordon
Bioelectrical impedance analysis for the evaluation of hepatic fibrosis in patients with chronic hepatitis C infection.
Digestive diseases and sciences 2008;53(7):1957-60.
2007: John G McHutchison; Geoffrey Dusheiko; Mitchell L Shiffman; Maribel Rodriguez-Torres; Samuel Sigal; Marc Bourliere; Thomas Berg; Stuart Gordon; Fiona M Campbell; Dickens Theodore; Nicole Blackman; Julian Jenkins; Nezam H Afdhal
Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C.
The New England journal of medicine 2007;357(22):2227-36.
2007: John G McHutchison; Bruce R Bacon; Stuart Gordon; Eric Lawitz; Mitchell Shiffman; Nezam H Afdhal; Ira M Jacobson; Andrew Muir; Mohammed J Al Adhami; Mary Lou Morris; Julie Lekstrom-Himes; Susan M Efler; Heather L Davis
Phase 1B, randomized, double-blind, dose-escalation trial of CPG 10101 in patients with chronic hepatitis C virus.
Hepatology (Baltimore, Md.) 2007;46(5):1341-9.
2006: Dean Y Kim; C Lim; Ravi Parasuraman; Mohammad Raoufi; Atsushi Yoshida; Juan Arenas; J Denny; Lauren Malinzak; M Almarastani; Dilip Moonka; Kimberly A Brown; Mary Ann Sherbondy; Stuart Gordon; Marwan Abouljoud
Renal disease burden following liver transplantation.
Transplantation proceedings 2006;38(10):3663-5.
2005: Riad Salem; Robert J Lewandowski; Bassel Atassi; Stuart Gordon; Vanessa L Gates; Omar Barakat; Ziad Sergie; Ching-Yee O Wong; Kenneth G Thurston
Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival.
Journal of vascular and interventional radiology : JVIR 2005;16(12):1627-39.
2005: Norah A Terrault; J-M Pawlotsky; J McHutchison; F Anderson; Mel Krajden; Stuart Gordon; IM Zitron; Robert P Perrillo; R Gish; Mark Holodniy; Michel Friesenhahn
Clinical utility of viral load measurements in individuals with chronic hepatitis C infection on antiviral therapy.
Journal of viral hepatitis 2005;12(5):465-72.
2005: Stuart Gordon
Occult viral hepatitis and noncirrhotic hepatocellular carcinoma.
The American journal of gastroenterology 2005;100(8):1754-7.
2005: Thomas K Rhee; Reed A Omary; Vanessa L Gates; Taofic Mounajjed; Andrew C Larson; Omar Barakat; Kent T Sato; Mary F Mulcahy; Stuart Gordon; Robert J Lewandowski; Riad Salem
The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma.
Journal of vascular and interventional radiology : JVIR 2005;16(8):1085-91.
2005: Kentaro Kikuchi; Zhe-Xiong Lian; Yasuhiko Kimura; Carlo Selmi; Guo-Xiang Yang; Stuart Gordon; Pietro Invernizzi; Mauro Podda; Ross Coppel; Aftab A Ansari; Susumu Ikehara; Hiroshi Miyakawa; M Eric Gershwin
Genetic polymorphisms of toll-like receptor 9 influence the immune response to CpG and contribute to hyper-IgM in primary biliary cirrhosis.
Journal of autoimmunity 2005;24(4):347-52.
2005: Yasunori Ichiki; Carlo Selmi; Shinji Shimoda; Hiromi Ishibashi; Stuart Gordon; M Eric Gershwin
Mitochondrial antigens as targets of cellular and humoral auto-immunity in primary biliary cirrhosis.
Clinical reviews in allergy & immunology 2005;28(2):83-91.
2005: Neal S Goldstein; Farnaz Hastah; Mark V Galan; Stuart Gordon
Fibrosis heterogeneity in nonalcoholic steatohepatitis and hepatitis C virus needle core biopsy specimens.
American journal of clinical pathology 2005;123(3):382-7.
2005: Stephen J Rulyak; Sue C Eng; Keyur Patel; John G McHutchison; Stuart Gordon; Kris V Kowdley
Relationships between hepatic iron content and virologic response in chronic hepatitis C patients treated with interferon and ribavirin.
The American journal of gastroenterology 2005;100(2):332-7.
2005: John G McHutchison; Mitchell L Shiffman; Ramsey C Cheung; Stuart Gordon; Teresa L Wright; John C Pottage; Lindsay McNair; Ene I Ette; Scott Moseley; John Alam
A randomized, double-blind, placebo-controlled dose-escalation trial of merimepodib (VX-497) and interferon-alpha in previously untreated patients with chronic hepatitis C.
Antiviral therapy 2005;10(5):635-43.
2005: Mark V Galan; Jeffrey A Potts; Ann L. Silverman; Stuart Gordon
The burden of acute nonfulminant drug-induced hepatitis in a United States tertiary referral center [corrected].
Journal of clinical gastroenterology 2005;39(1):64-7.
2004: Keyur Patel; Stuart Gordon; Ira Jacobson; Christophe Hézode; Esther Oh; Katie M Smith; Jean-Michel Pawlotsky; John G McHutchison
Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients.
Journal of hepatology 2004;41(6):935-42.
2004: Carlo Selmi; Marlyn J Mayo; Nancy Bach; Hiromi Ishibashi; Pietro Invernizzi; Robert G Gish; Stuart Gordon; Harlan I Wright; Bruce Zweiban; Mauro Podda; M Eric Gershwin
Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment.
Gastroenterology 2004;127(2):485-92.
2003: Stuart Gordon
New insights into acute hepatitis C.
Gastroenterology 2003;125(1):253-6.
2003: Veslav Stecevic; Martin M Pevzner; Stuart Gordon
Successful treatment of hepatitis B-associated vasculitis with lamivudine.
Journal of clinical gastroenterology 2003;36(5):451.
2002: Stephen Pianko; John G McHutchison; Stuart Gordon; Shanon Heaton; Zachary D Goodman; Keyur Patel; Cherise M Cortese; Elizabeth M Brunt; Bruce R Bacon; Lawrence M Blatt
Hepatic iron concentration does not influence response to therapy with interferon plus ribavirin in chronic HCV infection.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2002;22(4):483-9.
2001: Neal S Goldstein; A Soman; Stuart Gordon
Portal tract eosinophils and hepatocyte cytokeratin 7 immunoreactivity helps distinguish early-stage, mildly active primary biliary cirrhosis and autoimmune hepatitis.
American journal of clinical pathology 2001;116(6):846-53.
2001: John G McHutchison; J A Shad; Stuart Gordon; Timothy R Morgan; Mei-Hsiu Ling; Jean-Jacques Garaud; Janice K Albrecht; Jules L Dienstag
Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapy.
Journal of viral hepatitis 2001;8(6):414-20.
2001: Lorraine Comanor; F Anderson; M Ghany; Robert P Perrillo; E J Heathcote; Christopher H Sherlock; IM Zitron; David Hendricks; Stuart Gordon
Transcription-mediated amplification is more sensitive than conventional PCR-based assays for detecting residual serum HCV RNA at end of treatment.
The American journal of gastroenterology 2001;96(10):2968-72.
2001: Michael P Manns; John G McHutchison; Stuart Gordon; Vinod Rustgi; Mitchell Shiffman; Robert W Reindollar; Zachary D Goodman; K Koury; M Ling; Janice K Albrecht
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.
Lancet 2001;358(9286):958-65.
2001: Stuart Gordon
Treatment of viral hepatitis--2001.
Annals of medicine 2001;33(6):385-90.
2001: Mark V Galan; D Boyce; Stuart Gordon
Current pharmacotherapy for hepatitis B infection.
Expert opinion on pharmacotherapy 2001;2(8):1289-98.
2001: Karen L Lindsay; Christian Trepo; T Heintges; ML Shiffman; Stuart Gordon; J C Hoefs; Eugene R Schiff; Zachary D Goodman; M Laughlin; R Yao; Janice K Albrecht
A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C.
Hepatology (Baltimore, Md.) 2001;34(2):395-403.
2001: Ann L. Silverman; L H Qu; J Blow; IM Zitron; Stuart Gordon; Edward D Walker
Assessment of hepatitis B virus DNA and hepatitis C virus RNA in the common bedbug (Cimex lectularius L.) and kissing bug (Rodnius prolixus).
The American journal of gastroenterology 2001;96(7):2194-8.
2001: D A Lazarczyk; Neal S Goldstein; Stuart Gordon
Trovafloxacin hepatotoxicity.
Digestive diseases and sciences 2001;46(4):925-6.
2001: Mark V Galan; Stuart Gordon; Ann L. Silverman
Celecoxib-induced cholestatic hepatitis.
Annals of internal medicine 2001;134(3):254.
2000: John G McHutchison; T Poynard; Stephen Pianko; Stuart Gordon; A E Reid; Jules L Dienstag; T Morgan; R Yao; Jeff Albrecht
The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C. The International Hepatitis Interventional Therapy Group.
Gastroenterology 2000;119(5):1317-23.
2000: Neal S Goldstein; N Bayati; Ann L. Silverman; Stuart Gordon
Minocycline as a cause of drug-induced autoimmune hepatitis. Report of four cases and comparison with autoimmune hepatitis.
American journal of clinical pathology 2000;114(4):591-8.
2000: Stuart Gordon; JW Fang; Ann L. Silverman; John G McHutchison; Janice K Albrecht
The significance of baseline serum alanine aminotransferase on pretreatment disease characteristics and response to antiviral therapy in chronic hepatitis C.
Hepatology (Baltimore, Md.) 2000;32(2):400-4.
2000: Ann L. Silverman; J S Sekhon; S J Saginaw; D Wiedbrauk; Mamtha Balasubramaniam; Stuart Gordon
Tattoo application is not associated with an increased risk for chronic viral hepatitis.
The American journal of gastroenterology 2000;95(5):1312-5.
2000: Stuart Gordon
Antiviral therapy for chronic hepatitis B and C. Which patients are likely to benefit from which agents?
Postgraduate medicine 2000;107(2):135-8, 141-4.
2000: IM Zitron; M Laurinaitis; L Qu; Ann L. Silverman; Stuart Gordon
Immunological responses in patients who have spontaneously eradicated hepatitis C virus infection.
Viral immunology 2000;13(4):521-31.
1999: Milton G Mutchnick; Karen L Lindsay; Eugene R Schiff; G D Cummings; Henry D Appelman; RR Peleman; M Silva; K C Roach; F Simmons; S Milstein; Stuart Gordon; Murray Ehrinpreis
Thymosin alpha1 treatment of chronic hepatitis B: results of a phase III multicentre, randomized, double-blind and placebo-controlled study.
Journal of viral hepatitis 1999;6(5):397-403.
1999: Neal S Goldstein; D E Blue; RC Hankin; Susan Hunter; N Bayati; Ann L. Silverman; Stuart Gordon
Serum alpha-fetoprotein levels in patients with chronic hepatitis C. Relationships with serum alanine aminotransferase values, histologic activity index, and hepatocyte MIB-1 scores.
American journal of clinical pathology 1999;111(6):811-6.
1998: N Bayati; Ann L. Silverman; Stuart Gordon
Serum alpha-fetoprotein levels and liver histology in patients with chronic hepatitis C.
The American journal of gastroenterology 1998;93(12):2452-6.
1998: Stuart Gordon; PJ Dailey; Ann L. Silverman; B A Khan; V P Kodali; JC Wilber
Sequential serum hepatitis C viral RNA levels longitudinally assessed by branched DNA signal amplification.
Hepatology (Baltimore, Md.) 1998;28(6):1702-6.
1998: Gary L Davis; Rafael Esteban-Mur; Vinod Rustgi; J Hoefs; Stuart Gordon; C Trepo; ML Shiffman; Stefan Zeuzem; A Craxi; Mei-Hsiu Ling; Janice Albrecht
Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.
The New England journal of medicine 1998;339(21):1493-9.
1998: John G McHutchison; Stuart Gordon; Eugene R Schiff; ML Shiffman; W M Lee; Vinod Rustgi; Zachary D Goodman; Mei-Hsiu Ling; S Cort; Janice K Albrecht
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.
The New England journal of medicine 1998;339(21):1485-92.
1998: Stuart Gordon; N Bayati; Ann L. Silverman
Clinical outcome of hepatitis C as a function of mode of transmission.
Hepatology (Baltimore, Md.) 1998;28(2):562-7.
1997: Neal S Goldstein; J Underhill; Stuart Gordon; N Bayati; Ann L. Silverman
Comparative histologic features of liver biopsy specimens from patients coinfected with hepatitis G and C viruses with chronic hepatitis C virus alone: an age-, sex-, disease duration-, and transmission-matched controlled study of chronic hepatitis.
American journal of clinical pathology 1997;108(6):625-32.
1997: Ann L. Silverman; D L Piquette; C L Filipiak; J S Neill; N Bayati; Stuart Gordon
Alfa interferon treatment of hepatitis C virus RNA-positive patients with normal or near-normal alanine aminotransferase levels.
The American journal of gastroenterology 1997;92(10):1793-5.
1997: Douglas Simon; Stuart Gordon; M M Kaplan; R S Koff; F Regenstein; G Everson; Y M Lee; F Weiner; Ann L. Silverman; T Plasse; D Fedorczyk; M J Liao
Treatment of chronic hepatitis C with interferon alfa-n3: a multicenter, randomized, open-label trial.
Hepatology (Baltimore, Md.) 1997;25(2):445-8.
1996: Stuart Gordon
Extrahepatic manifestations of hepatitis C.
Digestive diseases (Basel, Switzerland) 1996;14(3):157-68.
1996: Frederick L Kiechle; T M Quattrociocchi-Longe; D A Brinton; Stuart Gordon; E Sykes; M Y Elkhalifa
Autoantibodies to specific enzymes: a review.
Annals of clinical and laboratory science 1996;26(3):195-207.
1996: Ann L. Silverman; D G McCray; Stuart Gordon; W T Morgan; Edward D Walker
Experimental evidence against replication or dissemination of hepatitis C virus in mosquitoes (Diptera:Culicidae) using detection by reverse transcriptase polymerase chain reaction.
Journal of medical entomology 1996;33(3):398-401.
1995: Neal S Goldstein; V P Kodali; Stuart Gordon
Histologic spectrum of cryptogenic chronic liver disease and comparison with chronic autoimmune and chronic type C hepatitis.
American journal of clinical pathology 1995;104(5):567-73.
1995: Stuart Gordon; T M Quattrociocchi-Longe; B A Khan; V P Kodali; J Chen; Ann L. Silverman; Frederick L Kiechle
Antibodies to carbonic anhydrase in patients with immune cholangiopathies.
Gastroenterology 1995;108(6):1802-9.
1995: V P Kodali; Stuart Gordon
Gastrointestinal hemorrhage secondary to crack cocaine.
Gastrointestinal endoscopy 1995;41(6):604-5.
1994: V P Kodali; Stuart Gordon; Ann L. Silverman; D G McCray
Cryptogenic liver disease in the United States: further evidence for non-A, non-B, and non-C hepatitis.
The American journal of gastroenterology 1994;89(10):1836-9.
1994: Stuart Gordon; V P Kodali; Ann L. Silverman; CF Dmuchowski; MS Urdea; C S Chan; J C Wilber
Levels of hepatitis C virus RNA and liver histology in chronic type C hepatitis.
The American journal of gastroenterology 1994;89(9):1458-61.
1994: Ann L. Silverman; J E Puccio; G W Kulesza; D G McCray; Stuart Gordon
HCV RNA is present in the menstrual blood of women with chronic hepatitis C infection.
The American journal of gastroenterology 1994;89(8):1201-2.
1993: Stuart Gordon; R S Elloway; J C Long; CF Dmuchowski
The pathology of hepatitis C as a function of mode of transmission: blood transfusion vs. intravenous drug use.
Hepatology (Baltimore, Md.) 1993;18(6):1338-43.
1992: Stuart Gordon; A H Patel; G W Kulesza; R E Barnes; Ann L. Silverman
Lack of evidence for the heterosexual transmission of hepatitis C.
The American journal of gastroenterology 1992;87(12):1849-51.
1992: Stuart Gordon; R A Meyer; B F Rosenberg
Laparoscopic diagnosis of subcapsular hepatic hemorrhage in pre-eclamptic liver disease.
Gastrointestinal endoscopy 1992;38(6):718-20.
1992: R E Barnes; R A Meyer; Stuart Gordon
Prevalence of anti-HCV in cryptogenic cirrhosis in a suburban Detroit community.
The American journal of gastroenterology 1992;87(8):1001-4.
1992: M Y Elkhalifa; Frederick L Kiechle; Stuart Gordon; J Chen; M D Poulik
A flow cytometric method to detect anti-pyruvate dehydrogenase antibody in primary biliary cirrhosis.
American journal of clinical pathology 1992;97(2):202-8.
1991: Stuart Gordon
Jaundice and cholestasis. Some common and uncommon causes.
Postgraduate medicine 1991;90(4):65-71.
1991: R A Meyer; Stuart Gordon
Epidemiology of hepatitis C virus infection in a suburban Detroit community.
The American journal of gastroenterology 1991;86(9):1224-6.
1991: Stuart Gordon; D J Polson; A Shirkhoda
Budd-Chiari syndrome complicating pre-eclampsia: diagnosis by magnetic resonance imaging.
Journal of clinical gastroenterology 1991;13(4):460-2.
1991: Stuart Gordon; R J Veneri; R F McFadden; K R Reddy; Eugene R Schiff
Major hemorrhage after percutaneous liver biopsy in patients with AIDS.
Gastroenterology 1991;100(6):1787.
1991: J R Levinson; Stuart Gordon
Liver diseases in the elderly.
Clinics in geriatric medicine 1991;7(2):371-85.
1990: Stuart Gordon; J C Watts; R J Veneri; F W Chandler
Focal hepatic candidiasis with perihepatic adhesions: laparoscopic and immunohistologic diagnosis.
Gastroenterology 1990;98(1):214-7.
1989: R J Veneri; Stuart Gordon; Darlene Fink-Bennett
Scintigraphic and culdoscopic diagnosis of bile peritonitis complicating liver biopsy.
Journal of clinical gastroenterology 1989;11(5):571-3.
1989: Stuart Gordon; A S Patel; R J Veneri; K A Keskey; S M Korotkin
Acute type A hepatitis presenting with hypotension, bradycardia, and sinus arrest.
Journal of medical virology 1989;28(4):219-22.
1989: A S Patel; Stuart Gordon
Large-volume paracentesis in outpatients.
Annals of internal medicine 1989;110(4):325-6.
1988: R J Veneri; Stuart Gordon
Anabolic steroid-induced cholestasis: choleretic response to corticosteroids.
Journal of clinical gastroenterology 1988;10(4):467-8.
1986: Stuart Gordon; K R Reddy; R Zeppa; Lennox Jeffers; Eugene R Schiff
Resection of metachronous hepatocellular carcinomas.
Southern medical journal 1986;79(12):1578-82.
1986: Stuart Gordon; K R Reddy; Alan Livingstone; Lennox Jeffers; Eugene R Schiff
Resolution of a contraceptive-steroid-induced hepatic adenoma with subsequent evolution into hepatocellular carcinoma.
Annals of internal medicine 1986;105(4):547-9.
1986: Stuart Gordon; K R Reddy; E E Gould; R McFadden; Christopher B O'Brien; M de Medina; Lennox Jeffers; Eugene R Schiff
The spectrum of liver disease in the acquired immunodeficiency syndrome.
Journal of hepatology 1986;2(3):475-84.
1985: Stuart Gordon; K R Reddy; Lennox Jeffers; Eugene R Schiff
"Love Boat" hepatitis.
Southern medical journal 1985;78(9):1142-3.
1985: K R Reddy; Stuart Gordon; Lennox Jeffers; Eugene R Schiff
Choledochocele: its clinical spectrum.
Gastroenterology 1985;88(4):1093-4.
1985: Stuart Gordon; Lennox Jeffers; M de Medina; K R Reddy; Eugene R Schiff
Immunoglobulin M antibody to hepatitis B core antigen and fulminant hepatitis B.
Annals of internal medicine 1985;102(3):415-6.
1984: Stuart Gordon; K R Reddy; L Schiff; Eugene R Schiff
Prolonged intrahepatic cholestasis secondary to acute hepatitis A.
Annals of internal medicine 1984;101(5):635-7.
1984: Stuart Gordon; C B Lauter
Mumps arthritis: a review of the literature.
Reviews of infectious diseases 1984;6(3):338-44.
1982: Stuart Gordon; C B Lauter
Mumps arthritis: unusual presentation as adult Still's disease.
Annals of internal medicine 1982;97(1):45-7.
1978: L S Greene; R Levine; M J Gross; Stuart Gordon
Distinguishing between malignant and cirrhotic ascites by computerized step-wise discriminant functional analysis of its biochemistry.
The American journal of gastroenterology 1978;70(5):448-54.